Uwe Meya is the founder of Minoryx Therapeutics. Minoryx Therapeutics has raised $120M in total funding. Latest round: Series C.
Dr. Uwe Meya is a medical professional who was appointed as Chief Medical Officer (CMO) at Minoryx Therapeutics in 2024. Minoryx Therapeutics, founded in 2011, is a biotech company specializing in orphan diseases. In his role, Meya oversees clinical development, including for candidates like MIN-102 (leriglitazone) for Friedreich's ataxia and other rare CNS diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library